Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Reporter Gene Assay Market Size Worth $9.0 Billion by 2027: Grand View Research, Inc.

Grand_View_Research_Logo

News provided by

Grand View Research, Inc.

Jun 01, 2020, 04:35 ET

Share this article

Share toX

Share this article

Share toX

SAN FRANCISCO, June 1, 2020 /PRNewswire/ --The global reporter gene assay market size is expected to reach USD 9.0 billion by 2027 registering a CAGR of 8.1%, according to a new report by Grand View Research, Inc. Reporter genes have significant demand as they are increasingly being used in studying gene expression and across several research studies in the fields of biochemistry, molecular biology, and pharmaceuticals. Reporter genes also play a pivotal role in quantifying the regulatory potential of unknown DNA sequences.

Key suggestions from the report:

  • Luciferase assays accounted for the highest revenue share in 2019 and is anticipated to retain its leading position throughout the forecast period
  • This is because luciferase enables precise measurement of signal maintaining consistency of the outcomes
  • In vitro studies application segment is projected to register the fastest CAGR of 8.3% from 2020 to 2027 owing to increasing need for rapid screening
  • Cell signaling pathways subsegment displayed the highest contribution to the clinical applications segment in 2019 owing to rise in adoption of reporter assays for GPCR signaling investigations and for screening chemicals that cause signaling disruption
  • These protocols are majorly employed in drug discovery programs, which has largely contributed to the growth of this segment in the global market throughout the forecast period
  • Hospital & diagnostic laboratories end-use segment is expected to register the highest CAGR from 2020 to 2027
  • North America accounted for the highest revenue share in 2019 owing to high penetration of cell-based assay technologies in the regional market
  • Asia Pacific is expected to witness the fastest CAGR from 2020 to 2027 due to rise in the number of research investigations that are focused on use of reporter genes for regulation of several disorders

Read 152 page research report with ToC on "Reporter Gene Assay Market Size, Share & Trends Analysis Report By Application (In Vitro Studies, Clinical), By Product (Luciferase, Beta-galactosidase), By Usage, By End Use, And Segment Forecasts, 2020 - 2027" at: https://www.grandviewresearch.com/industry-analysis/reporter-gene-assay-market

Rising penetration of these assays in diagnostic applications and their utility in understanding signal transduction pathways is expected to propel the market growth. Promega Corporation has developed vectors that can be used in investigation of signaling pathways. The company has also developed rapid response reporters to enhance the signal to background ratio.

Several other prominent market players also offer a strong product portfolio for luciferase assays. For instance, ThermoFisher Scientific offers a wide range of luciferase and Chemiluminescent assays to monitor the reporter activity. Moreover, presence of key market players such as Promega Corporation in developing economies is expected to drive the demand in this market.

Grand View Research has segmented the global reporter gene assay market on the basis of product, application, usage, end use, and region:

  • Reporter Gene Assay Product Outlook (Revenue, USD Million, 2016 - 2027)
    • Luciferase
    • Fluorescent Protein-related
    • Chloramphenicol Acetyltransferase
    • Beta-Galactosidase
    • Beta-Glucuronidase
    • Others
  • Reporter Gene Assay Application Outlook (Revenue, USD Million, 2016 - 2027)
    • Clinical Applications
      • Cell Signaling Pathways
      • Promoter Structural and Functional Analysis
      • Protein Interaction
    • In-vitro Studies
  • Reporter Gene Assay Usage Outlook (Revenue, USD Million, 2016 - 2027)
    • Drug Discovery Programs
    • Chemical Biology Programs
    • Biochemical Screening
    • Cell- & Organ-based Screening
  • Reporter Gene Assay End-use Outlook (Revenue, USD Million, 2016 - 2027)
    • Hospital & Diagnostic Laboratories
    • Academic & Research Institutes
    • Contract Research Organizations (CROs)
    • Pharmaceutical & Biotechnology Companies
  • Reporter Gene Assay Regional Outlook (Revenue, USD Million, 2016 - 2027)
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
    • Asia Pacific
      • China
      • Japan
      • India
      • Australia
    • Latin America
      • Brazil
      • Mexico
    • MEA
      • South Africa
      • Saudi Arabia
  • List of Key Companies of Reporter Gene Assay Market
    • QIAGEN
    • Thermo Fisher Scientific
    • Sartorius AG
    • Berthold Technologies GmbH & Co. KG
    • Promega Corp.
    • Marker Gene Technologies, Inc.
    • Merck KGaA
    • F. Hoffmann-La Roche AG
    • PerkinElmer Life Science
    • Bio-Rad Laboratories

Find more research reports on Biotechnology Industry, by Grand View Research:

  • CRISPR & Cas Genes Market – Global clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) genes market size was valued at USD 1.42 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 16.6% from 2020 to 2027.
  • Gene Therapy Market – Global gene therapy market size was estimated at USD 1.2 billion in 2019 and is projected to register a CAGR 16.6% over the forecast period.
  • DNA & Gene Chip Market – Global DNA & gene chip market size was valued at USD 4.50 billion in 2017 and is projected to exhibit a CAGR of 11.4% during the forecast period.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: +1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com  
Follow Us: LinkedIn | Twitter

SOURCE Grand View Research, Inc.

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Grand View Research Announces Strategic Investment and Technology Partnership with Dview to Accelerate AI & Analytics GTM

Grand View Research Announces Strategic Investment and Technology Partnership with Dview to Accelerate AI & Analytics GTM

Global market intelligence and advisory firm Grand View Research (GVR) today announced a strategic investment and long-term technology partnership...

Grand View Research Launches Advanced U.S. Healthcare Facility Mapping & Intelligence Platform to Enable Data-Driven Decision Making Across the Healthcare Ecosystem

Grand View Research Launches Advanced U.S. Healthcare Facility Mapping & Intelligence Platform to Enable Data-Driven Decision Making Across the Healthcare Ecosystem

Grand View Research (GVR), a global market intelligence and strategic consulting firm, today announced the expansion of its U.S. Healthcare Facility...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Biotechnology

Biotechnology

Surveys, Polls and Research

Surveys, Polls and Research

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.